Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
- PMID: 19304895
- DOI: 10.1189/jlb.1208761
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
Abstract
IFN-lambdas, including IFN-lambda1, IFN-lambda2, and IFN-lambda3, also known as IL-29, IL-28A, or IL-28B, are a newly described group of cytokines distantly related to the type I IFNs and IL-10 family members. The IFN-lambdaR complex consists of a unique ligand-binding chain, IFN-lambdaR1 (also designated IL-28Ralpha), and an accessory chain, IL-10R2, which is shared with receptors for IL-10-related cytokines. IFN-lambdas signal through the IFN-lambdaR and activate pathways of JAK-STATs and MAPKs to induce antiviral, antiproliferative, antitumor, and immune responses. In this review, we summarize recent findings about the biology of IFN-lambdas and their pathophysiological roles in viral infection, cancer, and immune responses of the innate and adaptive arms.
Similar articles
-
Type III Interferons in Viral Infection and Antiviral Immunity.Cell Physiol Biochem. 2018;51(1):173-185. doi: 10.1159/000495172. Epub 2018 Nov 15. Cell Physiol Biochem. 2018. PMID: 30439714 Review.
-
IFN-λs.Curr Opin Immunol. 2011 Oct;23(5):583-90. doi: 10.1016/j.coi.2011.07.007. Epub 2011 Aug 15. Curr Opin Immunol. 2011. PMID: 21840693 Free PMC article. Review.
-
Novel type III interferons produce anti-tumor effects through multiple functions.Front Biosci (Landmark Ed). 2013 Jun 1;18(3):909-18. doi: 10.2741/4152. Front Biosci (Landmark Ed). 2013. PMID: 23747856 Review.
-
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.Nat Immunol. 2003 Jan;4(1):69-77. doi: 10.1038/ni875. Epub 2002 Dec 16. Nat Immunol. 2003. PMID: 12483210
-
Biological activity of interleukins-28 and -29: comparison with type I interferons.Cytokine. 2005 Jul 21;31(2):109-18. doi: 10.1016/j.cyto.2005.04.003. Cytokine. 2005. PMID: 15899585
Cited by
-
Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.World J Gastroenterol. 2014 Dec 21;20(47):17830-8. doi: 10.3748/wjg.v20.i47.17830. World J Gastroenterol. 2014. PMID: 25548481 Free PMC article. Review.
-
Association of TNFRSF1A and IFNLR1 Gene Polymorphisms with the Risk of Developing Breast Cancer and Clinical Pathologic Features.Biochem Genet. 2021 Oct;59(5):1233-1246. doi: 10.1007/s10528-021-10060-z. Epub 2021 Mar 22. Biochem Genet. 2021. PMID: 33751344
-
Overview of the biology of type I interferons.Arthritis Res Ther. 2010;12 Suppl 1(Suppl 1):S1. doi: 10.1186/ar2881. Epub 2010 Apr 14. Arthritis Res Ther. 2010. PMID: 20392288 Free PMC article.
-
Interferon-lambda and therapy for chronic hepatitis C virus infection.Trends Immunol. 2011 Sep;32(9):443-50. doi: 10.1016/j.it.2011.07.002. Epub 2011 Aug 5. Trends Immunol. 2011. PMID: 21820962 Free PMC article. Review.
-
Interferon-gamma regulates the levels of bone formation effectors in a stage-dependent manner.Mol Biol Rep. 2022 Dec;49(12):12007-12015. doi: 10.1007/s11033-022-07993-y. Epub 2022 Oct 23. Mol Biol Rep. 2022. PMID: 36273336
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources